Generic group says FDA’s ophthalmic guideline should align with ICH Q3B(R2)
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ComplianceOTCPharmaceuticalsQuality Assurance and ControlUnited StatesRegulatory NewsJoanne S. EglovitchChemistry, Manufacturing and Controls (CMC)ComplianceOTCPharmaceuticalsQuality Assurance and ControlUnited States